Armata Pharmaceuticals (ARMP) Net Cash Flow Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.20% |
| Dec 31, 2025 | 0.54% |
| Sep 30, 2025 | 36.12% |
| Jun 30, 2025 | -14.00% |
| Mar 31, 2025 | -33.75% |
| Dec 31, 2024 | -24.19% |
| Sep 30, 2024 | -15.53% |
| Jun 30, 2024 | -29.41% |
| Mar 31, 2024 | 54.11% |
| Dec 31, 2023 | -45.26% |
| Sep 30, 2023 | 50.00% |
| Jun 30, 2023 | -43.48% |
| Mar 31, 2023 | 26.64% |
| Dec 31, 2022 | -32.35% |
| Sep 30, 2022 | -56.45% |
| Jun 30, 2022 | -27.69% |
| Mar 31, 2022 | 68.67% |
| Dec 31, 2021 | -24.78% |
| Sep 30, 2021 | -11.44% |
| Jun 30, 2021 | -10.27% |
| Mar 31, 2021 | 43.12% |
| Dec 31, 2020 | -21.38% |
| Sep 30, 2020 | -8.34% |
| Jun 30, 2020 | -10.95% |
| Mar 31, 2020 | 12.47% |
| Dec 31, 2019 | 3.68% |
| Sep 30, 2019 | -10.25% |
| Jun 30, 2019 | 30.67% |
| Mar 31, 2019 | 1.68% |
| Dec 31, 2018 | -31.37% |
| Sep 30, 2018 | 3.86% |
| Jun 30, 2018 | -18.25% |
| Mar 31, 2018 | 88.02% |